{"name": "The Medicines Company",
 "permalink": "the-medicines-company",
 "crunchbase_url": "http://www.crunchbase.com/company/the-medicines-company",
 "homepage_url": "http://www.themedicinescompany.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "973-290-6000",
 "description": "",
 "created_at": "Wed Jan 13 10:34:58 UTC 2010",
 "updated_at": "Wed Jan 13 12:19:04 UTC 2010",
 "overview": "\u003Cp\u003EThe Medicines Company is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax(R) (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex(R) (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Company also has two products in late stage development: cangrelor, an investigational antiplatelet agent, and oritavancin, a semi-synthetic lipoglycopeptide antibiotic. The Company\u0026#8217;s pipeline also includes a serine protease inhibitor, CU2010, in early-stage development.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       29],
      "assets/images/resized/0007/3162/73162v1-max-150x150.jpg"],
     [[250,
       49],
      "assets/images/resized/0007/3162/73162v1-max-250x250.jpg"],
     [[312,
       62],
      "assets/images/resized/0007/3162/73162v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Board of Directors",
    "person":
     {"first_name": "Armin",
      "last_name": "Kessler",
      "permalink": "armin-kessler",
      "image":
       {"available_sizes":
         [[[125,
            100],
           "assets/images/resized/0026/7620/267620v1-max-150x150.jpg"],
          [[125,
            100],
           "assets/images/resized/0026/7620/267620v1-max-250x250.jpg"],
          [[125,
            100],
           "assets/images/resized/0026/7620/267620v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Sr. Director, Product Development \u0026Director, Clinical Operations \u0026Associate Director, Clinical Operations \u0026Senior Clinical Project Manager ",
    "person":
     {"first_name": "Christina",
      "last_name": "Willwerth",
      "permalink": "christina-willwerth",
      "image":
       {"available_sizes":
         [[[150,
            92],
           "assets/images/resized/0025/7857/257857v1-max-150x150.jpg"],
          [[250,
            153],
           "assets/images/resized/0025/7857/257857v1-max-250x250.jpg"],
          [[350,
            215],
           "assets/images/resized/0025/7857/257857v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 420000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://ir.themedicinescompany.com/phoenix.zhtml?c=122204\u0026p=irol-newsArticle\u0026ID=1369038\u0026highlight=",
    "source_description": "The Medicines Company Acquires ApoA-I Milano From Pfizer",
    "acquired_year": 2009,
    "acquired_month": 12,
    "acquired_day": 22,
    "company":
     {"name": "ApoA-I Milano",
      "permalink": "apoa-i-milano",
      "image": null}},
   {"price_amount": null,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.marketwire.com/press-release/the-medicines-company-agrees-to-acquire-incline-therapeutics-inc-nasdaq-mdco-1736574.htm",
    "source_description": "The Medicines Company Agrees to Acquire Incline Therapeutics, Inc.",
    "acquired_year": 2012,
    "acquired_month": 12,
    "acquired_day": 12,
    "company":
     {"name": "Incline Therapeutics",
      "permalink": "incline-therapeutics",
      "image":
       {"available_sizes":
         [[[150,
            54],
           "assets/images/resized/0024/6779/246779v1-max-150x150.jpg"],
          [[185,
            67],
           "assets/images/resized/0024/6779/246779v1-max-250x250.jpg"],
          [[185,
            67],
           "assets/images/resized/0024/6779/246779v1-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [{"description": "",
    "address1": "8 Sylvan Way",
    "address2": "",
    "zip_code": "07054",
    "city": "Parsippany",
    "state_code": "NJ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        123],
       "assets/images/resized/0007/3164/73164v1-max-150x150.jpg"],
      [[250,
        205],
       "assets/images/resized/0007/3164/73164v1-max-250x250.jpg"],
      [[450,
        370],
       "assets/images/resized/0007/3164/73164v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}